5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.05▼ | 8.13▼ | 8.12▼ | 8.51▼ | 9.43▼ |
MA10 | 8.07▼ | 8.14▼ | 8.28▼ | 9.14▼ | 8.36▼ |
MA20 | 8.11▼ | 8.32▼ | 8.43▼ | 9.51▼ | 6.49▲ |
MA50 | 8.15▼ | 8.53▼ | 8.87▼ | 7.99▲ | N/A |
MA100 | 8.29▼ | 8.93▼ | 9.50▼ | 6.32▲ | N/A |
MA200 | 8.44▼ | 9.54▼ | 9.12▼ | 5.11▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.008▼ | -0.014▼ | -0.027▼ | -0.322▼ | N/A |
RSI | 32.303▼ | 35.990▼ | 35.775▼ | 42.341▼ | N/A |
STOCH | 37.310 | 33.690 | 23.915 | 12.159▼ | 78.764 |
WILL %R | -100.000▼ | -83.735▼ | -89.655▼ | -95.077▼ | -43.217 |
CCI | -242.849▼ | -93.038 | -89.289 | -128.342▼ | 39.986 |
Wednesday, January 13, 2021 03:46 PM
The MarketWatch News Department was not involved in the creation of this content. GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire via COMTEX/ -- GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire/ -- Precigen ...
|
Wednesday, January 13, 2021 01:11 PM
GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq:PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the ...
|
Wednesday, January 13, 2021 01:05 PM
PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/01/21 | 8.53 | 8.61 | 7.85 | 8.01 | 1,423,900 |
14/01/21 | 8.52 | 9.18 | 8.42 | 8.61 | 1,738,100 |
13/01/21 | 8.74 | 8.85 | 8.02 | 8.42 | 1,325,700 |
12/01/21 | 8.94 | 8.99 | 8.51 | 8.67 | 681,900 |
11/01/21 | 9.11 | 9.25 | 8.73 | 8.85 | 844,477 |
08/01/21 | 9.74 | 9.79 | 8.80 | 9.30 | 1,063,600 |
07/01/21 | 9.58 | 10.23 | 9.48 | 9.52 | 1,168,200 |
06/01/21 | 8.94 | 9.74 | 8.73 | 9.46 | 2,105,300 |
05/01/21 | 10.57 | 10.75 | 9.475 | 9.57 | 1,716,186 |
04/01/21 | 10.16 | 11.10 | 10.16 | 10.95 | 1,425,495 |
|
|
||||
|
|
||||
|
|